As expected, adriamycin (ADR) treatment caused severe glomerular sclerosis (Fig. 1B), elevated urinary albumin excretion (Fig. 1C), and reduced body weight (Fig. S1a) compared with the control group (CON). The gene discussed is ALB; the disease is Glomerular sclerosis.